StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
81
This month
3
This year
13
Publishing Date
2024 - 03 - 06
2
2024 - 01 - 04
2
2023 - 10 - 05
1
2023 - 09 - 14
1
2023 - 08 - 29
1
2023 - 08 - 10
1
2023 - 07 - 11
1
2023 - 06 - 16
1
2023 - 06 - 08
1
2023 - 05 - 26
1
2023 - 05 - 23
1
2023 - 05 - 10
1
2023 - 05 - 09
1
2023 - 05 - 03
2
2023 - 04 - 21
1
2023 - 04 - 06
1
2023 - 04 - 03
1
2023 - 03 - 23
1
2023 - 03 - 16
1
2023 - 03 - 13
1
2023 - 02 - 21
1
2023 - 02 - 07
1
2023 - 01 - 25
1
2022 - 12 - 19
1
2022 - 12 - 09
1
2022 - 12 - 01
1
2022 - 11 - 07
1
2022 - 11 - 04
1
2022 - 11 - 02
1
2022 - 10 - 20
2
2022 - 09 - 23
1
2022 - 09 - 15
1
2022 - 09 - 08
1
2022 - 09 - 05
1
2022 - 08 - 23
1
2022 - 08 - 01
1
2022 - 07 - 28
1
2022 - 07 - 21
1
2022 - 06 - 23
1
2022 - 06 - 03
1
2022 - 05 - 11
1
2022 - 05 - 10
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
Sector
Finance
6
Finance and insurance
4
Health technology
81
Manufacturing
1
Tags
Aml
1
Antibody
2
Asco
1
Blood
1
Business
8
Cancer
4
Candidate
2
Cell
3
Change
1
Clearance
1
Clinical-trials-phase-ii
5
Clinical-trials-phase-iii
2
Collaboration
2
Conference
20
Designation
1
Disease
1
Drug
3
Earnings
10
Europe
13
Events
22
Expansion
2
Fast track designation
1
Fda
2
Financial
11
Financial results
1
First
1
Growth
1
Iph45
2
Iph5201
2
Iph6101
4
Iph6401
1
Iph6501
1
License
1
Market
1
Meeting
1
Money
2
N/a
2
Natural
2
News
1
Ongoing
1
Payment
1
Pharma
74
Pharmaceutical
14
Phase 1
1
Phase 2
4
Phase 2b
1
Phase 3
1
Platform
2
Preclinical
2
Program
3
Regulatory
5
Report
4
Research
3
Results
14
Sanofi
6
Study
3
Trial
5
Universal
2
Update
15
Year
4
Entities
Abbott laboratories
219
Abbvie inc.
167
Alnylam pharmaceuticals, inc.
63
Alphabet inc.
31
Amarin corporation plc
30
Amgen inc.
132
Astellas pharma inc
70
Astrazeneca plc
176
Bausch health companies inc.
24
Baxter international inc.
41
Becton, dickinson and company
26
Biogen inc.
48
Biomarin pharmaceutical inc.
19
Biontech se
128
Boston scientific corporation
19
Bristol-myers squibb company
70
Byline bancorp, inc.
26
Csl ltd
22
Denali therapeutics inc.
19
Eli lilly and company
253
Endo international plc
18
Galapagos nv
35
Gilead sciences, inc.
35
Glaxosmithkline plc
272
Icon plc
12
Igm biosciences, inc.
37
Incyte corporation
102
Innate pharma s.a.
81
Innate pharma sa
81
Insulet corporation
15
Johnson & johnson
457
Kymera therapeutics, inc.
22
Medtronic plc
33
Mobiv acquisition corp
65
Moderna, inc.
22
Morgan stanley
14
Morphosys ag
32
Nektar therapeutics
38
Novartis ag
284
Novo nordisk a/s
100
Nurix therapeutics, inc.
14
Oncocyte corporation
31
Orange
49
Pegasus digital mobility acquisition corp.
17
Perrigo company
103
Pfizer, inc.
90
Provention bio, inc.
283
Ptc therapeutics, inc.
29
Rallybio corp
30
Rcf acquisition corp.
83
Reckitt benckiser group plc
20
Regeneron pharmaceuticals, inc.
188
Sanofi
3596
Takeda pharmaceutical company limited
51
Teva pharmaceutical industries limited
17
Teva pharmaceutical industries ltd
224
Therapeuticsmd, inc.
29
Thermo fisher scientific inc
36
Vaxart, inc.
30
Viatris inc.
81
Symbols
ABBV
1
ALPMF
1
ALPMY
1
AMGN
1
ARGX
1
AZN
4
AZNCF
1
BIIB
1
BMY
2
BNPQF
4
BNPQY
4
DNLI
1
GLAXF
1
GSK
1
INCY
1
IPHA
120
IPHYF
80
JNJ
1
LLY
1
MS
1
NVO
71
NVS
1
NVSEF
1
SIVB
1
SNY
109
SNYNF
81
TAK
2
TEVJF
1
VRTX
1
ZLAB
1
Exchanges
Nasdaq
81
Nyse
46
Crawled Date
2024 - 03 - 06
2
2024 - 01 - 04
2
2023 - 10 - 05
1
2023 - 09 - 14
1
2023 - 08 - 29
1
2023 - 08 - 10
1
2023 - 07 - 11
1
2023 - 06 - 16
1
2023 - 06 - 08
1
2023 - 05 - 26
1
2023 - 05 - 23
1
2023 - 05 - 10
1
2023 - 05 - 09
1
2023 - 05 - 03
2
2023 - 04 - 21
1
2023 - 04 - 06
1
2023 - 04 - 03
1
2023 - 03 - 23
1
2023 - 03 - 16
1
2023 - 03 - 13
1
2023 - 02 - 21
1
2023 - 02 - 07
1
2023 - 01 - 25
1
2022 - 12 - 19
1
2022 - 12 - 09
1
2022 - 12 - 01
1
2022 - 11 - 07
1
2022 - 11 - 04
1
2022 - 11 - 02
1
2022 - 10 - 20
2
2022 - 09 - 23
1
2022 - 09 - 15
1
2022 - 09 - 08
1
2022 - 09 - 05
1
2022 - 08 - 23
1
2022 - 08 - 01
1
2022 - 07 - 28
1
2022 - 07 - 21
1
2022 - 06 - 23
1
2022 - 06 - 03
1
2022 - 05 - 11
1
2022 - 05 - 10
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
Crawled Time
06:00
4
07:00
20
08:00
18
09:00
18
10:00
8
11:00
8
12:00
3
12:30
1
23:00
1
Source
www.biospace.com
79
www.globenewswire.com
1
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Innate pharma s.a.
symbols :
SNYNF
save search
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
Published:
2024-04-10
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-4.25%
|
O:
-0.32%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-9.62%
|
O:
-3.85%
H:
1.2%
C:
0.8%
iph45
pharma
drug
candidate
antibody
preclinical
Innate Pharma Announces Its Participation in Upcoming April 2024 Investor Conference
Published:
2024-04-09
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-1.38%
|
O:
0.28%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-3.83%
|
O:
-0.38%
H:
0.95%
C:
0.83%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-5.62%
|
O:
2.57%
H:
1.81%
C:
1.81%
pharma
conference
Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
Published:
2024-04-05
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-3.54%
|
O:
-1.77%
H:
0.0%
C:
-1.81%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-6.35%
|
O:
-3.44%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-6.0%
|
O:
-0.4%
H:
0.0%
C:
-5.22%
pharma
report
universal
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published:
2024-03-21
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-2.29%
|
O:
0.14%
H:
0.24%
C:
0.24%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-3.83%
|
O:
0.3%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-6.0%
|
O:
-4.51%
H:
4.25%
C:
0.96%
pharma
business
year
update
financial
results
Innate Pharma Announces Its Participation to Upcoming Investor Conference - March 19, 2024
Published:
2024-03-19
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-2.31%
|
O:
-0.02%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-5.25%
|
O:
-1.51%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-1.67%
|
O:
0.84%
H:
4.56%
C:
0.83%
pharma
conference
Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
Published:
2024-03-14
(Crawled : 09:00)
- biospace.com/
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-5.82%
|
O:
0.23%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-6.0%
|
O:
-2.4%
H:
3.69%
C:
3.28%
pharma
conference
year
financial
results
Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma
Published:
2024-03-06
(Crawled : 12:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-1.01%
|
O:
0.0%
H:
0.8%
C:
0.8%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-4.29%
|
O:
-0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-8.56%
|
O:
0.78%
H:
1.93%
C:
0.97%
iph6501
first
study
Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
Published:
2024-03-06
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-1.01%
|
O:
0.0%
H:
0.8%
C:
0.8%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-4.29%
|
O:
-0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-8.56%
|
O:
0.78%
H:
1.93%
C:
0.97%
iph45
pharma
drug
antibody
preclinical
Innate Pharma Announces Its Participation to Upcoming March 2024 Investor Conference
Published:
2024-02-21
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-1.49%
|
O:
1.7%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-3.99%
|
O:
-0.57%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-9.27%
|
O:
-2.32%
H:
0.0%
C:
0.0%
pharma
conference
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
$20.2
510
|
Health Technology
|
-1.6%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
$138.24
800
|
Health Technology
|
12.13%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
$9.47
520K
|
Manufacturing
|
-13.68%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.255
0.72%
200K
|
Health Technology
|
-8.11%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-7.41%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$146.39
0.45%
1.8M
|
Health Technology
|
-7.44%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
$39.685
1.06%
380K
|
Health Technology
|
-3.58%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
$731.1
-1.99%
1M
|
Health Technology
|
1.83%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.56
0.54%
1.8M
|
Health Technology
|
-2.91%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$164.91
0.15%
1.2M
|
Health Technology
|
-4.57%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
News
|
$14.125
-0.67%
45K
|
Health Technology
|
-25.59%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
News
|
$395.42
0.49%
290K
|
Health Technology
|
-5.63%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-1.49%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-8.91%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$52.6
-0.42%
380K
|
Health Technology
|
-8.68%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$191.45
0.49%
310K
|
Health Technology
|
-20.26%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
$68.545
0.27%
1.2M
|
Health Technology
|
11.16%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$360.47
0.58%
45K
|
Health Technology
|
-5.61%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
$265.32
0.98%
550K
|
Health Technology
|
-10.02%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
Published:
2024-01-12
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-11.92%
|
O:
0.71%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-13.05%
|
O:
0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-15.77%
|
O:
0.0%
H:
0.36%
C:
0.36%
pharma
Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
Published:
2024-01-04
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-7.51%
|
O:
1.62%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-9.09%
|
O:
1.12%
H:
0.93%
C:
0.77%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-15.47%
|
O:
6.47%
H:
3.65%
C:
-2.36%
pharma
Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
Published:
2024-01-04
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-7.51%
|
O:
1.62%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-9.09%
|
O:
1.12%
H:
0.93%
C:
0.77%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-15.47%
|
O:
6.47%
H:
3.65%
C:
-2.36%
fda
pharma
program
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published:
2023-12-19
(Crawled : 08:00)
- biospace.com/
NVO
|
$123.43
0.55%
1.4M
|
Health Technology
|
25.81%
|
O:
0.91%
H:
0.72%
C:
0.11%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-6.07%
|
O:
0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-4.08%
|
O:
13.88%
H:
0.0%
C:
-3.58%
pharma
natural
cell
sanofi
Innate Pharma Announces Leadership Change - December 18, 2023
Published:
2023-12-18
(Crawled : 10:00)
- biospace.com/
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-4.89%
|
O:
1.25%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-2.49%
|
O:
2.9%
H:
2.02%
C:
-1.21%
pharma
change
Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023
Published:
2023-12-11
(Crawled : 08:00)
- biospace.com/
IPHYF
|
$2.65
104.6%
300
|
Health Technology
|
11.81%
|
O:
9.45%
H:
0.0%
C:
-1.7%
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-0.54%
|
O:
0.5%
H:
1.67%
C:
0.1%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-1.51%
|
O:
2.15%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-8.91%
|
O:
-1.16%
H:
0.39%
C:
-4.31%
sar4435
pharma
iph6101
cell
results
sanofi
Innate Pharma to Host Virtual KOL Event on Lacutamab
Published:
2023-11-27
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-2.62%
|
O:
-0.36%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-3.4%
|
O:
1.04%
H:
0.17%
C:
0.11%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-2.89%
|
O:
2.07%
H:
1.21%
C:
1.21%
pharma
Innate Pharma Reports Third Quarter 2023 Financial Results and Business Update
Published:
2023-11-14
(Crawled : 09:00)
- biospace.com/
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
0.29%
|
O:
0.68%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
3.52%
|
O:
6.61%
H:
9.39%
C:
6.61%
pharma
business
update
financial
results
Innate Pharma Announces Conference Call for Third Quarter 2023 Business Update
Published:
2023-11-07
(Crawled : 08:00)
- biospace.com/
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-0.36%
|
O:
-1.32%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-9.62%
|
O:
-2.31%
H:
2.76%
C:
1.18%
pharma
conference
business
update
Innate Pharma Announces Its Participation to Upcoming November 2023 Investor Conferences
Published:
2023-10-27
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-11.93%
|
O:
-18.18%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-14.36%
|
O:
-15.73%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
2.3K
|
Health Technology
|
-4.47%
|
O:
-2.85%
H:
12.13%
C:
3.77%
pharma
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
79%
21%
Top 10 Gainers
AGBA
|
News
|
$1.22
205.0%
86M
|
Finance
EGOX
|
$0.0606
68.33%
250M
|
NVFY
|
$3.45
63.51%
20M
|
Consumer Durables
ZCMD
|
$1.98
36.55%
27M
|
Commercial Services
CHRO
|
$1.66
35.51%
70K
|
n/a
INDO
|
$5.43
33.09%
10M
|
Energy Minerals
PAPL
|
$2.07
26.22%
550K
|
RWOD
|
$10.08
26.05%
5.6M
|
n/a
AULT
|
$0.304
25.57%
47M
|
Manufacturing
HUSA
4
|
$2.07
23.95%
2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.